Prognostic Impact of Angiogenic Markers in Non¨CSmall-Cell Lung Cancer is Related to Tumor Size
详细信息    查看全文
文摘

Background

It is thought that different families of angiogenic factors stimulate angiogenesis at different stages of tumor development. Our aim was to study whether the prognostic impact of vascular endothelial growth factors (VEGFs) and receptors (VEGFRs), platelet-derived growth factors (PDGFs) and receptors (PDGFRs) and fibroblast growth factor-2 (FGF-2) were associated with tumor size in non¨Csmall-cell lung cancer (NSCLC).

Patients and Methods

Tumor tissue samples were obtained from 335 patients who had undergone resection for stage I-IIIA NSCLC, and tissue microarrays (TMAs) were constructed. Immunohistochemical techniques were used to evaluate the expression of VEGF-A, VEGF-C, VEGFR-2, VEGFR-3, PDGF-A, PDGF-B, PDGFR-¦Á, PDGFR-¦Â, and FGF-2. Tumor size was categorized using the same cutoffs as in the 7th TNM classification for lung cancer.

Results

In multivariate analysis, high VEGFR-2 (HR, 1.87, [95 % CI, 1.02-3.45]; P = .043), VEGFR-3 (HR, 2.18 [95 % CI, 1.28-3.71]; P = .004) and the combination of high VEGF-A and high VEGFR-2 expression (low/low vs. high/high; HR, 3.28 [95 % CI, 1.47-7.31]; P = .004) were independent negative prognostic factors in T2a tumors. High PDGF-B expression (HR, 11.72 [95 % CI, 3.07-44.76]; P < .001) was an independent prognostic factor in T2b tumors.

Conclusion

The prognostic impact of angiogenic factors depend in part on tumor size. VEGF-A/VEGFR-2 and VEGFR-3 seem to have their main impact in T2a tumors, while PDGF-B is a strong and independent prognostic factor in T2b tumors.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700